Trials / Completed
CompletedNCT05367908
A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind
Discoveries - Different Immunization Boosters for Covid-19: Effect on Response in Antibodies
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,501 (actual)
- Sponsor
- ModernaTX, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate antibody levels with respect to time since receiving a COVID-19 booster shot. The study will be decentralized, where participants can complete all study tasks at home. Self-reported participant information will be collected via surveys conducted at intake and monthly throughout the study. Participants will also perform monthly at-home capillary blood draws via YourBio devices that will be mailed to the designated laboratory for sample processing and antibody testing.
Conditions
Timeline
- Start date
- 2022-04-11
- Primary completion
- 2022-08-14
- Completion
- 2022-08-14
- First posted
- 2022-05-10
- Last updated
- 2022-10-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05367908. Inclusion in this directory is not an endorsement.